Sciences

Jupiter Asset Management Increases Stake in USANA Health … – Best Stocks


Jupiter Asset Management Ltd., a leading investment management firm, has increased its stake in USANA Health Sciences, Inc. by 48.2% during the first quarter of this year. According to the company’s recently filed Form 13F with the Securities & Exchange Commission, Jupiter Asset Management now holds 18,244 shares of USANA Health Sciences, following an additional purchase of 5,935 shares in the same quarter. This equates to approximately 0.09% ownership of USANA Health Sciences and has an estimated value of $1,147,000 as of the end of the reporting period.

USANA Health Sciences (NYSE:USNA) recently announced its quarterly earnings results for the period ending July 25th. The company reported earnings per share (EPS) of $0.89 for the quarter, surpassing market expectations by $0.19 per share. With a net margin of 6.69% and a return on equity of 14.33%, USANA Health Sciences demonstrated strong financial performance during this period. The company generated revenues totaling $238.20 million, which exceeded analysts’ estimates of $224.77 million for the quarter. It is important to note that earnings per share for USANA Health Sciences in the same quarter last year were $1.00.

Financial analysts have been closely monitoring USANA Health Sciences and several research reports have been issued regarding its stock performance recently. StockNews.com issued coverage on shares of USANA Health Sciences and categorized it as a “strong-buy” rating for potential investors to consider. Similarly, Sidoti initiated coverage on shares of USANA Health Sciences on June 23rd with a “buy” rating assigned to the stock’s potential value.

DA Davidson, another reputable research firm specializing in securities analysis and market trends,revised their price target on USANA Health Sciences from $56.00 to $62.00 following their own research report released on July 27th. Such positive sentiment from industry experts is indicative of the confidence in USANA Health Sciences’ future growth potential.

Looking ahead, equities analysts predict that USANA Health Sciences, Inc. will achieve an EPS of 3.22 for the current year, based on their analysis of the company’s financial performance and market trends. It remains to be seen how these forecasts will materialize, however, with strong quarterly earnings and favorable ratings from reputable financial analysts, the outlook for USANA Health Sciences appears promising.

In conclusion, Jupiter Asset Management Ltd.’s recent increase in its holdings of USANA Health Sciences shares demonstrates their confidence in the company’s future prospects. With a strong quarterly performance surpassing market expectations and positive recommendations from research reports, there is growing optimism surrounding USANA Health Sciences’ stock potential. Investors should closely monitor this company as it continues to develop and expand its presence in the health sciences industry.

USANA Health Sciences, Inc.

USNA

Buy

Updated on: 18/08/2023

Price Target

Current $63.35

Concensus $76.00


Low $76.00

Median $76.00

High $76.00

Show more

Social Sentiments

9:00 PM (UTC)

Date:18 August, 2023

Show more

Analyst Ratings

Analyst / firm Rating
D.A. Davidson Buy

Show more

USANA Health Sciences Sees Increased Investor Activity and Insider Trading Activity, Presents Promising Investment Opportunity in the Health and Wellness Sector


USANA Health Sciences, Inc., a leading global health and wellness company, has seen significant activity from large investors in recent months. Notably, Vanguard Group Inc. expanded its holdings in the company by 0.8% during the first quarter, now owning 1,510,852 shares valued at approximately $120 million. Similarly, Dimensional Fund Advisors LP increased its stake by 0.4% and now holds 566,420 shares worth $45 million.

State Street Corp also demonstrated faith in USANA Health Sciences by growing its shareholdings by 1.7% during the third quarter, bringing its total ownership to 392,324 shares with an estimated value of $21.99 million. Geode Capital Management LLC joined in on the action as well, increasing its holdings by 1.5% in the fourth quarter and now owning 225,960 shares amounting to $12.02 million.

Joining this list of reputable investors is Charles Schwab Investment Management Inc., which raised its stake by an impressive 12.2% during the fourth quarter. The firm now owns 189,437 shares valued at $10.08 million.

These activities indicate a high level of confidence among institutional investors and hedge funds who collectively own around 53.50% of USANA Health Sciences’ stock.

In other news concerning USANA Health Sciences, Director Xia Ding sold 606 shares on July 27th for an average price of $65.60 per share, resulting in a total transaction value of $39,753.60. Following this transaction, Ding’s personal holdings stand at 1,421 shares worth approximately $93,217.60.

Additionally, insider Daniel A. Macuga sold 2,234 shares on June 14th at an average price of $62.88 per share for a total transaction value of $140,473.92.

Over the last 90 days, corporate insiders collectively sold 13,341 shares of USANA Health Sciences’ stock, amounting to a total value of $864,911. Notably, these insider transactions represent only 0.33% of the company’s total shares.

On August 18th, USNA opened at $63.80 on the New York Stock Exchange (NYSE). The stock’s 50-day moving average stands at $63.17, while its 200-day moving average is slightly higher at $62.91. Over the past year, the company has seen a low of $48.61 and a high of $73.25.

USANA Health Sciences holds a market capitalization of approximately $1.23 billion and boasts a price-to-earnings (P/E) ratio of 19.45. With a price-to-earnings-growth (PEG) ratio of 1.66 and a beta of 0.76, the firm presents an intriguing investment opportunity for both existing shareholders and potential investors.

In conclusion, USANA Health Sciences has garnered attention from notable institutional investors while witnessing significant insider trading activity. The company’s solid financial performance combined with its promising market potential make it an intriguing prospect in the health and wellness sector for those looking to diversify their portfolios or expand their holdings in this particular industry segment.





Source link

Lucas Leclerc

Tel un mélodiste des pixels, je suis Lucas Leclerc, un Compositeur de Contenus Digitaux orchestrant des récits qui fusionnent la connaissance et l'imagination. Mon passage à l'Université Catholique de Lyon a accordé une symphonie à ma plume. Telle une partition éclectique, mes écrits se déploient des arcanes de la sécurité internationale aux méandres de la politique, des étoiles de la science aux prédictions des bulletins météo. Je navigue entre les lignes avec la même aisance qu'un athlète soucieux de sa santé. Chaque article est une note de transparence, une mélodie d'authenticité. Rejoignez-moi dans cette composition numérique où les mots s'entremêlent pour former une toile captivante de connaissances et de créativité, où la sécurité mondiale danse avec les étoiles, où les sphères politiques se fondent avec la météorologie, et où chaque paragraphe est une sonate pour la compréhension globale.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button